Key result
Type 2 diabetes mellitus with advanced cardiomyopathy was associated with a markedly decreased mean perfusion reserve index compared to healthy subjects (0.736 vs 2.35, p=0.001).
Why the study?
Does myocardial perfusion reserve measured by CMR differ in patients with advanced cardiomyopathy and type 2 diabetes mellitus compared to healthy volunteers and idiopathic cardiomyopathy patients?
Cross-Sectional (n=37)
Does myocardial perfusion reserve measured by CMR differ in patients with advanced cardiomyopathy and type 2 diabetes mellitus compared to healthy volunteers and idiopathic cardiomyopathy patients?
Absolute Event Rate: 0.736% vs 2.35%
p-value: p=0.001
In patients with type 2 diabetes and advanced cardiomyopathy, myocardial perfusion reserve is markedly decreased, indicating microvascular dysfunction, though it does not correlate with the degree of LV ejection fraction impairment.
Reduced perfusion reserve signals microvascular dysfunction in diabetic cardiomyopathy; leaves open its prognostic value or therapeutic role beyond LVEF.
Background Diabetic cardiomyopathy is characterized by microvascular disease and interstitial fibrosis, which lead to progressive heart failure; however, its pathogenesis remains uncertain. Perfusion cardiac magnetic resonance (CMR) has been proven efficient to detect subclinical myocardial perfusion reserve abnormalities in context of diabetes type 1 in the absence of epicardial coronary artery disease. Objective To evaluate myocardial perfusion reserve in patients with advanced cardiomyopathy and type 2 diabetes mellitus but without obstructive coronary artery disease (DM2). We hypothesized that impaired myocardial perfusion reserve deteriorates as systolic dysfunction progresses. Method and results Mean myocardial perfusion relative upslope at rest and during hyperaemia (adenosine 140 mg/kg/min) and mean perfusion reserve index (MPRI), were examined in 11 clinically stable DM2 patients (mean (SD) age 67 (8.4) years, range of 54–83 years; NYHA I–II; EF: 37.4 (11.3) %) using perfusion cardiac magnetic resonance (CMR). They were compared against 16 patients with idiopathic cardiomyopathy (mean age: 62 (14.0) years, range of 37–82 years; NYHA I–II; mean EF: 46 (12.3) %) and 10 healthy volunteers with normal ECG and no evidence of cardiac disease (mean age 35 (11.2) years, range of 27–66 years; mean EF: 65 (5.1) %). DM2 patients had lower hyperemic perfusion relative upslope (0.2 (0.07) v. 0.31 (0.04) p = 0.001) and MPRI (0.736 (0.233) v. 2.35 (0.284), p = 0.001) compared to healthy subjects. Results of DM2 and DCM patients were similar. MPRI in DM2 patents with moderate LV dysfunction was not different from patients with severe dysfunction. Conclusion In patients with DM2 myocardial perfusion reserve is markedly decreased, suggestive of microvascular disease. In this small cohort MPRI impairment did not correlate to the LV EF deterioration.
No takes yet. Share an insight, caveat, or question.
Bratis et al. (2014) conducted a cross-sectional in Diabetic cardiomyopathy (n=37). Type 2 diabetes mellitus with advanced cardiomyopathy vs. Healthy volunteers was evaluated on Mean perfusion reserve index (MPRI) (p=0.001). Type 2 diabetes mellitus with advanced cardiomyopathy was associated with a markedly decreased mean perfusion reserve index compared to healthy subjects (0.736 vs 2.35, p=0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: